Cocrystal Pharma (COCP) Revenue & Revenue Breakdown
Cocrystal Pharma Revenue Highlights
00
Cocrystal Pharma Revenue by Period
Cocrystal Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $2.01M | -69.32% |
| 2019-12-31 | $6.56M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | -100.00% |
| 2015-12-31 | $78.00K | 766.67% |
| 2014-12-31 | $9.00K | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2012-12-31 | $17.19M | 36.38% |
| 2011-12-31 | $12.61M | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | - |
Cocrystal Pharma generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Cocrystal Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $136.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $144.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $5.43K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $510.00K | 4.29% |
| 2020-09-30 | $489.00K | -11.73% |
| 2020-06-30 | $554.00K | 20.17% |
| 2020-03-31 | $461.00K | 14.68% |
| 2019-12-31 | $402.00K | -18.29% |
| 2019-09-30 | $492.00K | -16.89% |
| 2019-06-30 | $592.00K | -88.34% |
| 2019-03-31 | $5.08M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | -100.00% |
| 2015-09-30 | $24.00K | -11.11% |
| 2015-06-30 | $27.00K | - |
| 2015-03-31 | $27.00K | 200.00% |
| 2014-12-31 | $9.00K | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-12-31 | $-5.76M | -376.19% |
| 2013-09-30 | $2.09M | 6.70% |
| 2013-06-30 | $1.96M | -3.59% |
| 2013-03-31 | $2.03M | -47.64% |
| 2012-12-31 | $3.87M | -20.82% |
| 2012-09-30 | $4.89M | -0.37% |
| 2012-06-30 | $4.91M | 39.95% |
| 2012-03-31 | $3.51M | -4.29% |
| 2011-12-31 | $3.67M | -6.70% |
| 2011-09-30 | $3.93M | 52.88% |
| 2011-06-30 | $2.57M | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Cocrystal Pharma generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Cocrystal Pharma Revenue Breakdown
Cocrystal Pharma Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 20 | Jun 20 |
|---|---|---|
| Collaboration Revenue | $489.00K | $554.00K |
Latest
Cocrystal Pharma's latest quarterly revenue breakdown by segment (product or service), as of Sep 20: Collaboration Revenue (100.00%).
Cocrystal Pharma Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 20 | Jun 20 |
|---|---|---|
| Collaboration Revenue | $489.00K | $554.00K |
Latest
Cocrystal Pharma's latest quarterly revenue breakdown by geography, as of Sep 20: Collaboration Revenue (100.00%).
Cocrystal Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRKR | Marker Therapeutics | $6.59T | $861.18K |
| BOLT | Bolt Biotherapeutics | $7.69M | $2.17M |
| EVGN | Evogene | $5.64M | $4.19M |
| IMRN | Immuron | $1.80M | $2.36M |
| BRTX | BioRestorative Therapies | $401.00K | $11.80K |
| TRAW | Traws Pharma | $226.00K | - |
| DWTX | Dogwood Therapeutics | - | - |
| IMNN | Imunon | - | - |
| COCP | Cocrystal Pharma | - | - |
| CING | Cingulate | - | - |
| SNSE | Sensei Biotherapeutics | - | - |